Chapter 4
Catheter Closure of Atrial and Ventricular Septal Defects
Ignacio Inglessis MD,
Neil Wilson MB BS, DCH, FRCP, FRCP(CH),
Michael de Moor MBBCh, FACC, FSCAI,
Ignacio Inglessis MD
Adult Congenital Heart Disease Program, Department of Cardiology, Massachusetts General Hospital, Boston, MA, USA
Search for more papers by this authorNeil Wilson MB BS, DCH, FRCP, FRCP(CH)
Consultant Paediatric Cardiologist Director
Paediatric Cardiac Catheter Laboratory, Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, UK
Search for more papers by this authorMichael de Moor MBBCh, FACC, FSCAI
Pediatric Cardiology Division, Floating Hospital for Children, Tufts University Medical Center, Boston, MA, USA
Search for more papers by this authorIgnacio Inglessis MD,
Neil Wilson MB BS, DCH, FRCP, FRCP(CH),
Michael de Moor MBBCh, FACC, FSCAI,
Ignacio Inglessis MD
Adult Congenital Heart Disease Program, Department of Cardiology, Massachusetts General Hospital, Boston, MA, USA
Search for more papers by this authorNeil Wilson MB BS, DCH, FRCP, FRCP(CH)
Consultant Paediatric Cardiologist Director
Paediatric Cardiac Catheter Laboratory, Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, UK
Search for more papers by this authorMichael de Moor MBBCh, FACC, FSCAI
Pediatric Cardiology Division, Floating Hospital for Children, Tufts University Medical Center, Boston, MA, USA
Search for more papers by this authorBook Editor(s):Jürgen Haase MD, PhD, FESC, FACC,
Hans-Joachim Schäfers MD, PhD,
Horst Sievert MD, FESC, FACC,
Ron Waksman MD, FACC,
Jürgen Haase MD, PhD, FESC, FACC
Professor of Medicine Consultant Cardiologist
Kardiocentrum Frankfurt, Klinik Rotes Kreuz, Frankfurt/Main, Germany
Search for more papers by this authorHans-Joachim Schäfers MD, PhD
Professor of Surgery Chair
Department of Thoracic and Cardiovascular Surgery, University Hospital Saarland, Homburg/Saar, Germany
Search for more papers by this authorHorst Sievert MD, FESC, FACC
Professor of Medicine Head
Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorRon Waksman MD, FACC
Professor of Medicine Associate Director Director
Division of Cardiology, Washington, DC, USA
Experimental Cardiology, Washington Hospital Center, Washington, DC, USA
Search for more papers by this authorFirst published: 10 May 2010
Summary
This chapter contains sections titled:
-
Atrial septal defect closure
-
Ventricular septal defect closure
-
References
References
- King TD & Mills NL. (1974) Nonoperative closure of atrial septal defects. Surgery 75: 383–388.
- Lock JE, Rome JJ, Davis R, et al. (1989) Transcatheter closure of atrial septal defects. Experimental studies. Circulation 79: 1091–1099.
- Boutin C, Mesewe NN, Smallhorn JF, et al. (1993) Echocardio-graphic follow up of atrial septal defects after catheter closure by double umbrella device. Circulation 88: 621–627.
- Prieto LR, Foreman CK, Cheatham JP, & Latson LA. (1995) Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella. Am J Cardiol 76: 695–698.
- Babic UU, Grujicic S, Popovic Z, et al. (1991) Double-umbrella device for transvenous closure of patent ductus arteriosus and atrial septal defect: first experience. J Interv Cardiol 4: 283–296.
- Rao PS & Sideris EG. (2001) Centering-on demand buttoned device: its role in transcatheter occlusion of atrial septal defects. J Interv Cardiol 14: 81–89.
- Rickers C, Hamm C, Stern H, et al. (1998) Percutaneous closure of secundum atrial septal defect with a new self centering device (“angel wings”). Heart 80: 517–521.
- Hoffman JE & Kaplan S. (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39: 1890.
- Joy J, Kartha CC, & Balakrishnan KG. (1993) Structural basis for mitral valve dysfunction associated with ostium secundum atrial septal defects. Cardiology 82: 409–414.
- Fuse S, Tomita H, Hatakeyama K, et al. (2001) Effects of size of an atrial septal defect on shunt volume. Am J Cardiol 88: 1447–1450.
- Craig RJ & Selzer A. (1968) Natural history and prognosis of atrial septal defect. Circulation 37: 805–815.
- Dalen JE, Haynes FW, & Dexter L. (1967) Life expectancy with atrial septal defect. Influence of complicating pulmonary vascular disease. JAMA 200: 442–446.
- Balzer D, Kort H, Day R, et al. (2002) Inhaled Nitric Oxide as Preoperative Test (INOP test I): the INOP Test Study Group. Circulation 106: I76–81.
- Bruch L, Winkelmann A, Sonntag S, et al. (2007) Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure. J Interv Cardiol 21: 44–49.
- Boccalandro F, Baptista E, Muench A, et al. (2004) Comparison of intracardiac echocardiography versus transesophageal guidance for percutaneous transcatheter closure of atrial septal defect. Am J Cardiol 93: 437–440.
- Rigateli G, Cardaioli P, Braggion G, et al. (2007) Transesophageal echocardiography and intracardiac echocardiography differently predict technical challenges or failures of interatrial shunts catheter based closure. J Interv Cardiol 20: 77–81.
- Passeri J, Inglessis I, Palacios I, & Picard M. (2007) Initial experience with real time three-dimensional transesophageal echocardiography in patients undergoing transcatheter atrial septal defect closure. Circulation 116: II_401 (abs.).
- Balzer J, Kuhl H, Rassaf T, et al. (2008) Real-time transesophageal three-dimensional echocardiography for guidance of atrial septal defect closures. Eur Heart J 97: 565–574.
- Sader M, De Moor M, Pomenrantsev E, & Palacios I. (2003) Percutaneous transcatheter patent foramen closure using the right internal jugular venous approach. Catheter Cardiovasc Interv 60: 536–539.
- Shim D, Lloyd T, & Beekman R III. (1999) Transhepatic therapeutic cardiac catheterization: a new option for the pediatric interventionalist. Catheter Cardiovasc Interv 4: 41–45.
- Divekar A, Gaamangwe T, Shaikh N, et al. (2005) Cardiac perforations after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 45: 1213–1218.
- Du ZD, Hijazi ZM, Kleinman CS, et al. (2002) Amplatzer investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter non randomized trial. J Am Coll Cardiol 39: 1836–1844.
- Jones T, Latson L, Zahn E, et al. (2007) Results of the US Multi-center Pivotal Study of the Helex septal occluded for percutaneous closure of secundum atrial septal defects. J Am Coll Cardiol 49: 2215–2221.
- Veldtman GR, Razack V, Siu S, et al. (2001) Right ventricular form and function after percutaneous atrial septal defect closure. J Am Coll Cardiol 37: 2108–2113.
- Brochi MC, Baril JF, Dore A, et al. (2002) Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 106: 1821–1826.
- Omeish A & Hijazi ZM. (2001) Transcatheter closure of atrial septal defects in children and adults using the Amplatzer Septal Occluder. J Interv Cardiol 14: 37–44.
- Butera G, Caminati M, Chessa M, et al. (2004) CardioSEAL/ STARFlex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septa defects. Am Heart J 148: 507–510.
- Post M, Suttorp M, Jaarsma W, & Plokker T. (2006) Comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defect in adults: a single center experience. Catheter Cardiovasc Interv 67: 438–443.
- Carminati M, Chessa M, Buter G, et al. (2001) Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow up. J Interv Cardiol 14: 319–324.
- Nugent AW, Britt A, Gauvreau K, et al. (2006) Device closure rates of simple atrial septal defects optimized by the STARFlex device. J Am Coll Cardiol 48: 538–544.
- Zahn E, Wilson N, Cutright W, & Latson L. (2001) Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 104: 711–716.
- Krumsdorf U, Ostermayer S, Billinger K, et al. (2004) Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 21: 302–309.
- Lock JE, Block PC, McKay RG, Bain DS, & Keane JF. (1988) Transcatheter closure of ventricular septal defects. Circulation 82: 1681–1685.
- Bridges N, Perry S, Keane J, et al. (1991) Preoperative trans-catheter closure of congenital muscular ventricular septal defects. N Engl J Med 324: 1312–1317.
- Lims DS, Forbes TJ, Rothman A, Lock JE, & Landzburg MJ. (2007) Transcatheter closure of high risk muscular ventricular septal defects with the CardioSEAL occluder: initial report from the CardioSEAL VSD registry. Catheter Cardiovasc Interv 70: 740–744.
- Carminati M, Butera G, Chessa M, for the Investigators of the European VSD Registry (2007) Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 28: 2361–2368.
- Amin Z, Gu X, Berry JM, et al. (1999) New device for closure of muscular ventricular septal defects in a canine model. Circulation 100: 320–328.
- Hijazi ZM, Hakim F, Haweleh AA, et al. (2002) Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder. Catheter Cardiovasc Interv 56: 508–515.
- Hoffman JIE. (1987) Incidence, mortality and natural history. In Anderson RH, Macartney FJ, Shinebourne EA, & Tynan M (eds). Pediatric Cardiology. Edinburgh: Churchill Livingstone, pp. 3–13.
- Mullins CE. (2006) Ventricular septal defect occlusions. In: Mullins CE (ed). Cardiac Catheterization in Congenital Heart Disease. Oxford: Blackwell Publishing, pp. 803–841.
- McCartthy KP, Leung PKC, & Ho SY. (2005) Perimembranous and muscular ventricular septal defects—morphology revisited in the era of device closure. J Interv Cardiol 18: 507–513.
- Hijazi ZM. (2003) Device closure of ventricular septal defects. Catheter Cardiovasc Interv 60: 107–114.
- Knauth A, Lock JE, Perry SB, et al. (2004) Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation 110: 501–507.
- Marshall AC, Love BA, Lang P, et al. (2003) Staged repair of Tetralogy of Fallot and diminutive pulmonary arteries using a fenestrated ventricular septal defect patch. J Thorac Cardiovasc Surg 126: 1427–1433.
- Sullivan I. (2007) Transcatheter closure of perimembranous ventricular septal defect: is the risk of heart block too high? Heart 93: 284–286.
- Bacha EA, Galantowicz ME, Cheatham JP, et al. (2005) Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol 26: 169–175.
- Lowe HC, Jang IK, Yoerger DM, MacGillivray TE, de Moor M, & Palacios IF. (2003) Compassionate use of the Amplatzer ASD closure device for residual postinfarction ventricular septal rupture following surgical repair. Catheter Cardiovasc Interv 59: 230–233.
- Hijazi ZM, Hakim F, Haweleh AA, et al. (2002) Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder. Catheter Cardiovasc Interv 56: 508–515.
- Carminati M, Butera G, Chessa M, et al. Investigators of the European VSD Registry. (2007) Transcatheter closure of congenital ventricular septal defects: Results of the European Registry. Eur Heart J 28: 2361–2368.
- Lim DS, Forbes TJ, Rothman A, Lock JE, & Landzburg MJ. (2007) Transcatheter closure of high risk muscular ventricular septal defects with the CardioSEAL occluder: initial report from the CardioSEAL VSD Registry. Catheter Cardiovasc Interv 70: 740–744.
- Holzer R, Balzer D, Amin Z, et al. (2004) Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Catheter Cardiovasc Interv 61: 196–201.
